// App-Quantinova.ai

81 : Long-term safety with sarilumab plus conventional synthetic disease-modifying antirheumatic drugs and sarilumab monotherapy in rheumatoid arthritis: an integrated analysis with 9,000 patient-years of follow-up

Researchers

Presenter

  • Roy Fleischmann

Principal Investigators

  • Yong Lin

  • Gregory St John

  • Dsire van der Heijde

  • Chunfu Qiu

  • Juan Carlos Gomez-Reino

  • Jose Antonio Maldonado-Cocco

  • Marina Stanislav

  • Bruno Seriolo

  • Lesley Tranter

  • Gerd R Burmester

Medical Centers

  • Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Department of Medicine, Dallas, TX

  • Clinical Science, Sanofi Genzyme, Bridgewater, NJ

  • Medical Analytics, Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA

  • Rheumatology, Leiden University Medical Centre, Leiden, NETHERLANDS

  • Biostatistics, Sanofi Genzyme, Bridgewater, NJ

  • Rheumatology, IDIS, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago, SPAIN

  • Buenos Aires University School of Medicine, Buenos Aires University, Buenos Aires, ARGENTINA

  • Rheumatology Research Institute, n. a. V.A. Nassonova, Moscow, RUSSIAN FEDERATION

  • Internal Medicine, University of Genova, Genova, ITALY

  • Rheumatology, Sanofi Genzyme, Oxford, UNITED KINGDOM

  • Department of Rheumatology and Clinical Immunology, Charite - Universitatsmedizin Berlin, Berlin, Germany

Locations

  • United States

  • Netherlands

  • Spain

  • Argentina

  • Russia

  • Italy

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Sarilumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT01061736

  • NCT01709578

  • NCT01768572

  • NCT02057250

  • NCT01764997

  • NCT01217814

  • NCT02332590

  • NCT02121210

  • NCT01146652

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved